文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ST段抬高型心肌梗死的延迟就诊者：行动呼吁 - Suppr | 超能文献

ST段抬高型心肌梗死的延迟就诊者：行动呼吁

Late Presenters with ST-Elevation Myocardial Infarction: A Call to Action.

作者信息

De Luca Leonardo, Veneziano Francesco Antonio, Karaboue Michele

机构信息

Department of Cardio-Thoracic-Vascular Sciences, A.O. San Camillo-Forlanini, 00151 Rome, Italy.

UniCamillus-Saint Camillus International, University of Health Sciences, 00131 Rome, Italy.

出版信息

J Clin Med. 2022 Sep 1;11(17):5169. doi: 10.3390/jcm11175169.

DOI:10.3390/jcm11175169

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9457385/

Abstract

The emphasis on timely coronary reperfusion in the setting of ST-segment elevation Myocardial Infarction (STEMI) comes from older studies suggesting a significant reduction in mortality among patients treated with fibrinolytic therapy during the first hours after onset of symptoms and a progressive increase in fatal events in those presenting later [...].

摘要

对ST段抬高型心肌梗死（STEMI）患者及时进行冠状动脉再灌注的重视源于较早的研究，这些研究表明，在症状发作后的最初几个小时内接受纤维蛋白溶解疗法治疗的患者死亡率显著降低，而症状出现较晚的患者致命事件则逐渐增加[……]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad15/9457385/a0d61c6a1b8b/jcm-11-05169-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad15/9457385/a0d61c6a1b8b/jcm-11-05169-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad15/9457385/a0d61c6a1b8b/jcm-11-05169-g001.jpg

相似文献

1

Late Presenters with ST-Elevation Myocardial Infarction: A Call to Action.ST段抬高型心肌梗死的延迟就诊者：行动呼吁

J Clin Med. 2022 Sep 1;11(17):5169. doi: 10.3390/jcm11175169.

2

Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]).症状发作 12 至 24 小时内的 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗再灌注（来自前瞻性全国观察性研究 [PL-ACS]）。

Am J Cardiol. 2011 Feb 15;107(4):501-8. doi: 10.1016/j.amjcard.2010.10.008. Epub 2010 Dec 31.

3

Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).半剂量阿替普酶与直接经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死中的疗效和安全性：EARLY-MYO 试验（阿替普酶溶栓后早期常规冠状动脉造影与急性 ST 段抬高型心肌梗死直接经皮冠状动脉介入治疗的比较）。

Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27.

4

Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial.早期与晚期就诊的ST段抬高型心肌梗死患者在直接经皮冠状动脉介入治疗期间冠状动脉内注射依替巴肽的随机试验

Cardiol Ther. 2016 Dec;5(2):203-213. doi: 10.1007/s40119-016-0073-3. Epub 2016 Nov 14.

5

Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者症状发作 12 小时后行直接经皮冠状动脉介入治疗再灌注可获益。

Circ Cardiovasc Interv. 2018 Sep;11(9):e006842. doi: 10.1161/CIRCINTERVENTIONS.118.006842.

6

Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort.根据再灌注治疗方式，ST 段抬高型心肌梗死患者的 5 年生存率：法国急性 ST 段抬高和非 ST 段抬高型心肌梗死注册研究（FAST-MI）2005 队列。

Circulation. 2014 Apr 22;129(16):1629-36. doi: 10.1161/CIRCULATIONAHA.113.005874. Epub 2014 Mar 21.

7

Electrocardiogram to predict reperfusion success in late presenters with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.心电图预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死延迟就诊患者的再灌注成功率。

J Electrocardiol. 2020 Mar-Apr;59:74-80. doi: 10.1016/j.jelectrocard.2020.01.008. Epub 2020 Jan 25.

8

[Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].[ST段抬高型心肌梗死（STEMI）的循证管理。欧洲心脏病学会（ESC）2010年最新指南]

Herz. 2010 Dec;35(8):558-64. doi: 10.1007/s00059-010-3401-8.

9

Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者晚期就诊的长期结局。

J Am Coll Cardiol. 2021 Apr 20;77(15):1859-1870. doi: 10.1016/j.jacc.2021.02.041.

10

[Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction].[链激酶与阿替普酶对ST段抬高型急性心肌梗死心肌再灌注心电图及血管造影征象的比较作用]

Srp Arh Celok Lek. 2008 Sep-Oct;136(9-10):481-7. doi: 10.2298/sarh0810481t.

引用本文的文献

1

Radiation Recall Pneumonitis: The Open Challenge in Differential Diagnosis of Pneumonia Induced by Oncological Treatments.放射性回忆性肺炎：肿瘤治疗所致肺炎鉴别诊断中的公开挑战

J Clin Med. 2023 Feb 10;12(4):1442. doi: 10.3390/jcm12041442.

本文引用的文献

1

Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.经皮心肌血运重建治疗晚期 ST 段抬高型心肌梗死患者。

J Am Coll Cardiol. 2021 Sep 28;78(13):1291-1305. doi: 10.1016/j.jacc.2021.07.039.

2

Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者晚期就诊的长期结局。

J Am Coll Cardiol. 2021 Apr 20;77(15):1859-1870. doi: 10.1016/j.jacc.2021.02.041.

3

COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction.

COVID-19 大流行与 ST 段抬高型心肌梗死患者的机械并发症有关。

Open Heart. 2021 Feb;8(1). doi: 10.1136/openhrt-2020-001497.

4

Mouse models of myocardial infarction: comparing permanent ligation and ischaemia-reperfusion.心肌梗死的小鼠模型：比较永久性结扎和缺血再灌注。

Dis Model Mech. 2020 Nov 18;13(11):dmm046565. doi: 10.1242/dmm.046565.

5

Collaterals in STEMI patients: An uncommon but critical lifeline.STEMI 患者的侧支循环：一条不常见但至关重要的生命线。

Catheter Cardiovasc Interv. 2020 Sep 1;96(3):534-535. doi: 10.1002/ccd.29208.

6

Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.中国 COVID-19 大流行期间 STEMI 患者的管理和结局。

J Am Coll Cardiol. 2020 Sep 15;76(11):1318-1324. doi: 10.1016/j.jacc.2020.06.039. Epub 2020 Aug 19.

7

Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center.COVID-19 大流行对 ST 段抬高型心肌梗死患者的影响：来自英国心脏中心的见解。

Am Heart J. 2020 Aug;226:45-48. doi: 10.1016/j.ahj.2020.04.022. Epub 2020 May 11.

8

Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017.1997-2017 年 AMIS Plus 注册研究：晚期 STEMI 患者时间趋势分析。

Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):741-748. doi: 10.1016/j.rec.2019.10.001. Epub 2019 Dec 4.

9

Very late presentation in ST elevation myocardial infarction: Predictors and long-term mortality.ST段抬高型心肌梗死的极晚期就诊：预测因素及长期死亡率

Int J Cardiol Heart Vasc. 2019 Feb 20;22:156-159. doi: 10.1016/j.ijcha.2019.02.002. eCollection 2019 Mar.

10

Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者症状发作 12 小时后行直接经皮冠状动脉介入治疗再灌注可获益。

Circ Cardiovasc Interv. 2018 Sep;11(9):e006842. doi: 10.1161/CIRCINTERVENTIONS.118.006842.